Chapter 34: Endocrine Pancreas & Glucose Regulation
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Endocrine Pancreas & Glucose Regulation begins by detailing the functional anatomy of the Islets of Langerhans, describing the paracrine relationships and vascular flow between alpha, beta, delta, F, and epsilon cells, which secrete glucagon, insulin (and amylin), somatostatin, pancreatic polypeptide, and ghrelin, respectively. A significant portion of the text elucidates the biosynthesis of insulin from preproinsulin and the clinical relevance of C-peptide as a marker of endogenous beta-cell function. The molecular mechanisms of glucose-stimulated insulin secretion are rigorously examined, tracing the pathway from GLUT2 transport and glucokinase activity—the primary glucose sensor—to ATP generation, closure of ATP-sensitive potassium channels (the target of sulfonylurea drugs), membrane depolarization, and calcium-mediated exocytosis. The text also covers the incretin effect, where gut hormones like GLP-1 enhance insulin response. The physiological actions of insulin are explored through its receptor signaling (tyrosine kinase activity, IRS proteins, PI3K/Akt pathway), leading to GLUT4 translocation in muscle and adipose tissue, glycogen synthesis, lipogenesis, and protein anabolism. Conversely, the chapter analyzes glucagon secretion during hypoglycemia and its catabolic actions in the liver via cAMP signaling, promoting glycogenolysis, gluconeogenesis, ureagenesis, and ketogenesis through the regulation of carnitine acyltransferase. The discussion extends to the pathophysiology of Diabetes Mellitus, differentiating between the autoimmune destruction of beta cells in Type 1 Diabetes and the insulin resistance coupled with beta-cell failure characteristic of Type 2 Diabetes and prediabetes. Finally, the summary addresses the acute complications of diabetes, such as diabetic ketoacidosis and hyperosmolar states, as well as chronic microvascular and macrovascular consequences, while also highlighting emerging research on the gut microbiome's role in metabolic health.